Laboratory detection of carbapenemases among Gram-negative organisms
Clinical Microbiology Reviews · 10.12.2024 · 37 (4)
DOI: 10.1128/cmr.00054-22 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical Microbiology Reviews, erschienen am 10.12.2024. Verfasst von Patricia J Simner und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. Hauptthemen laut MEDLINE: Bacterial Proteins, beta-Lactamases, Gram-Negative Bacteria, Gram-Negative Bacterial Infections. Die Arbeit wurde bisher 63-mal zitiert (Crossref) und nennt 286 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
The carbapenems remain some of the most effective options available for treating patients with serious infections due to Gram-negative bacteria. Carbapenemases are enzymes that hydrolyze carbapenems and are the primary method driving carbapenem resistance globally. Detection of carbapenemases is required for patient management, the rapid implementation of infection prevention and control (IP&C) protocols, and for epidemiologic purposes. Therefore, clinical and public health microbiology laboratories must be able to detect and report carbapenemases among predominant Gram-negative organisms from both cultured isolates and direct from clinical specimens for treatment and surveillance purposes. There is not a “one size fits all” laboratory approach for the detection of bacteria with carbapenemases, and institutions need to determine what fits best with the goals of their antimicrobial stewardship and IP&C programs. Luckily, there are several options and approaches available for clinical laboratories to choose methods that best suits their individual needs. A laboratory approach to detect carbapenemases among bacterial isolates consists of two steps, namely a screening process ( e.g. , not susceptible to ertapenem, meropenem, and/or imipenem), followed by a confirmation test ( i.e. , phenotypic, genotypic or proteomic methods) for the presence of a carbapenemase. Direct from specimen testing for the most common carbapenemases generally involves detection via rapid, molecular approaches. The aim of this article is to provide brief overviews on Gram-negative bacteria carbapenem-resistant definitions, types of carbapenemases, global epidemiology, and then describe in detail the laboratory methods for the detection of carbapenemases among Gram-negative bacteria. We will specifically focus on the Enterobacterales, Pseudomonas aeruginosa , and Acinetobacter baumannii complex.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
- Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
- Cummings School of Medicine, University of Calgary, Calgary, Calgary, Alberta, Canada.
- Alberta Precision Laboratories, Diagnostic Laboratory, Calgary, Alberta, Canada.
- University of Pretoria, Pretoria, Gauteng, South Africa.
- Alberta Precision Laboratories, Public Health Laboratory, Calgary, Alberta, Canada.
ORCID-Profile: Patricia J Simner, Johann D D Pitout, Tanis C Dingle
Zitieren
APA
Simner, P. J., Pitout, J. D. D., & Dingle, T. C. (2024). Laboratory detection of carbapenemases among Gram-negative organisms. Clinical Microbiology Reviews, 37(4). https://doi.org/10.1128/cmr.00054-22
Vancouver
Simner PJ, Pitout JDD, Dingle TC. Laboratory detection of carbapenemases among Gram-negative organisms. Clinical Microbiology Reviews. 2024;37(4). doi:10.1128/cmr.00054-22
BibTeX
@article{Simner2024,
author = {Simner, Patricia J and Pitout, Johann D D and Dingle, Tanis C},
title = {Laboratory detection of carbapenemases among Gram-negative organisms},
journal = {Clinical Microbiology Reviews},
year = {2024},
volume = {37},
number = {4},
doi = {10.1128/cmr.00054-22}
}
EUVIMED